Ritonavir Tablet
Product Images NDC 31722-597
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ritonavir (NDC 31722-597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ritonavircamberlogo (Ritonavircamberlogo)
Ritonavircamberlogo2 (Ritonavircamberlogo2)
Ritonavirstructure (Ritonavirstructure)
Ritonavirtabletsusp100mg120slabel (Ritonavirtabletsusp100mg120slabel)
This is a description of Ritonavir Tablets, USP manufactured by Camber Pharmaceuticals, Inc. The tablet should be stored at room temperature, swallowed whole with meals and not be chewed, broken or crushed. It is important to avoid taking it with medicines that are not recommended. The usual dosage should be followed as directed in the package. There is a US contact number provided for any concerns or queries. The package should not be used if the seal over the bottle is broken or missing. There is also a warning to not expose the product to high humidity outside the original or USP equivalent tight container for longer than two weeks.*
Ritonavirtabletsusp100mg30slabel (Ritonavirtabletsusp100mg30slabel)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.